Connect Sign In
The CDC has cited research in which the University of Utah’s HERO Project and ARUP Laboratories played a key role. The research is integral to new physical distancing guidelines.
Jonathan Genzen, MD, PhD, ARUP Laboratories’ chief operations officer, explains how the Johnson & Johnson SARS-CoV-2 vaccine works, and how it differs from the Moderna and Pfizer-BioNTech vaccines.
By the end of January, approximately 22–28% of Salt Lake County residents either had been infected with SARS-CoV-2 or had been vaccinated against the virus, according to the Utah HERO Project.
Diagnostic laboratory testing remains important for detecting active COVID-19 infection in vaccinated, partially vaccinated, and unvaccinated individuals.
Point-of-care antigen testing with the Abbott BinaxNOW COVID-19 Ag Card is not as sensitive as standard NAATs for detecting SARS-CoV-2 in asymptomatic college students, according to a study.
ARUP Laboratories announced that it is sequencing variants of SARS-CoV-2 in specimens positive for COVID-19 to enable detection of the more contagious “United Kingdom (UK) variant” of the virus.
ARUP and University of Utah Health continue to research the safety and efficacy of COVID-19 convalescent plasma (CCP) in four multicenter randomized clinical trials.
Which types of innovation, adaptation, and acceleration happened in diagnostic technology companies in the face of the COVID-19 pandemic? Are the intensity and fast-moving strategies even sustainable?
A recording of an hour-long webinar updating the status of diagnostic testing for SARS-CoV-2 nearly a year after the first tests were introduced is now available to watch for free.
ARUP Laboratories has made a new resource available to laboratory leaders and others in healthcare to help explain how the first FDA-approved SARS-CoV-2 vaccines work.
